Source: Eur Respir Mon; 2003: 23: 138–163
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G.F. Joos, P. Geppetti. Neural mechanisms in asthma. Eur Respir Mon; 2003: 23: 138–163

Member's Comments

No comment yet.

Related content which might interest you: Regulation of tracheal parasympathetic nerve ganglia development by eosinophils Source: International Congress 2017 – New immune markers for asthma and COPD Year: 2017 Interaction of the glutamatergic and nitrergic signaling system in the airway hyperreactivity Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Modulatory role of tachykinin NK1 receptor in cholinergic contraction of mouse trachea Source: Eur Respir J 2003; 21: 3-10 Year: 2003 Optogenetic activation of mouse airway parasympathetic neurons to provoke bronchoconstriction Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma Year: 2019 Modulation of cholinergic contractions of airway smooth muscle by cathinone: potential beneficial effects in airway diseases Source: Eur Respir J 2008; 32: 579-584 Year: 2008 TRPM3: A regulator of airway sensory nerves and respiratory reflexes Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Two distinct phenotypes of pulmonary vagal sensory C-fibers Source: Annual Congress 2003 - Respiratory structure and mechanisms: current concepts Year: 2003 Characterisation of TRPA1 activation on sensory nerves Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 Airway sensory nerves Source: International Congress 2016 – State-of-the-art research techniques in Royal Brompton Hospital and Imperial College London II Year: 2016 Experimental airways hyperreactivity and modulation of glutamatergic and nitrergic signalling Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Role of vagal afferents in load compensatory responses of pharynx muscles Source: Eur Respir J 2003; 22: Suppl. 45, 357s Year: 2003 Influence of abdominal and/or pulmonary vagal afferents on 5-HT respiratory effects in newborn mammals Source: Eur Respir J 2003; 22: Suppl. 45, 469s Year: 2003 Cholinergic muscarinic receptors and airway remodelling in severe asthma Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 EPAC drives the anti-tussive effect of EP4 receptors on airway sensory nerves Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020 Investigating the role of prostaglandin D2 in airway sensory nerve firing: Relevance to disease Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Involvement of capsaicin-sensitive nerves in the bronchoconstriction induced by intraoesophageal HCl infusion in the rabbits Source: Eur Respir J 2002; 20: Suppl. 38, 105s Year: 2002 Eosinophil-induced intracellular signalling in cholinergic nerve cells Source: Eur Respir J 2003; 22: Suppl. 45, 454s Year: 2003 The Rho-kinase inhibitor Y-27632 reduces cholinergic nerve-mediated contraction but not neurotransmitter release from guinea-pig isolated trachea Source: Eur Respir J 2004; 24: Suppl. 48, 97s Year: 2004 Attenuation of ozone-induced tachypnoea by activation of dopamine D2 receptors in the rat: involvement of vagal bronchopulmonary C fibres Source: Eur Respir J 2001; 18: Suppl. 33, 408s Year: 2001